UCLA offers high-intensity focused ultrasound (HIFU) treatment for prostate cancer
UCLA’s Department of Urology is offering a new, minimally invasive alternative for treating prostate cancer — high-intensity focused ultrasound (HIFU) — which uses sound waves to selectively target and destroy diseased tissue.
MR-targeted biopsy poised to become the new standard in prostate cancer diagnosis
Research advances at UCLA with funding from the National Cancer Institute have led to major changes in the way prostate cancer is diagnosed and managed.
UCLA researchers advance immunotherapy approaches for genitourinary cancers
Breakthroughs in immunotherapy are revolutionizing the treatment of genitourinary cancer, with new treatment options available or imminent for patients with kidney, bladder and prostate cancer.
Specialized program offers comprehensive prostate cancer planning in a single visit
Approximately one in six men is diagnosed with prostate cancer. For many, evaluating the risks and benefits of the complex array of treatment options can mean multiple physician appointments across several specialties and over an extended period of time.
New options for the diagnosis and treatment of bladder cancer
Approximately 74,000 Americans are diagnosed with bladder cancer each year. Over the past decade, mortality rates for the disease have declined slightly in women but have remained fairly stable in men.
